Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Brian W. Kunkle, Benjamin Grenier‐Boley, Rebecca Sims, et al.
Nature Genetics (2019) Vol. 51, Iss. 3, pp. 414-430
Open Access | Times Cited: 2487

Showing 1-25 of 2487 citing articles:

Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Connie W. Tsao, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2023) Vol. 147, Iss. 8
Open Access | Times Cited: 4252
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Justin M. Long, David M. Holtzman
Cell (2019) Vol. 179, Iss. 2, pp. 312-339
Open Access | Times Cited: 2363
Alzheimer disease
David S. Knopman, Hélène Amieva, Ronald C. Petersen, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 1528
New insights into the genetic etiology of Alzheimer’s disease and related dementias
Céline Bellenguez, Fahri Küçükali, Iris E. Jansen, et al.
Nature Genetics (2022) Vol. 54, Iss. 4, pp. 412-436
Open Access | Times Cited: 1508
Tutorial: a guide to performing polygenic risk score analyses
Shing Wan Choi, Timothy Shin Heng Mak, Paul F. O’Reilly
Nature Protocols (2020) Vol. 15, Iss. 9, pp. 2759-2772
Open Access | Times Cited: 1423
The Amyloid-β Pathway in Alzheimer’s Disease
Harald Hampel, John Hardy, Kaj Blennow, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 10, pp. 5481-5503
Open Access | Times Cited: 1058
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Seth S. Martin, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2024) Vol. 149, Iss. 8
Open Access | Times Cited: 934
A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease
Douglas P. Wightman, Iris E. Jansen, Jeanne E. Savage, et al.
Nature Genetics (2021) Vol. 53, Iss. 9, pp. 1276-1282
Open Access | Times Cited: 722
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
Bruno Dubois, Nicolas Villain, Giovanni B. Frisoni, et al.
The Lancet Neurology (2021) Vol. 20, Iss. 6, pp. 484-496
Open Access | Times Cited: 701
APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches
Alberto Serrano‐Pozo, Sudeshna Das, Bradley T. Hyman
The Lancet Neurology (2020) Vol. 20, Iss. 1, pp. 68-80
Open Access | Times Cited: 660
Alzheimer's disease
José Arguedas López, Hector M. González, Gabriel C. Léger
Handbook of clinical neurology (2019), pp. 231-255
Closed Access | Times Cited: 634
Brain cell type–specific enhancer–promoter interactome maps and disease - risk association
Alexi Nott, Inge R. Holtman, Nicole G. Coufal, et al.
Science (2019) Vol. 366, Iss. 6469, pp. 1134-1139
Open Access | Times Cited: 611
A human brain vascular atlas reveals diverse mediators of Alzheimer’s risk
Andrew C. Yang, Ryan T. Vest, Fabian Kern, et al.
Nature (2022) Vol. 603, Iss. 7903, pp. 885-892
Open Access | Times Cited: 533
ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries
Paul M. Thompson, Neda Jahanshad, Christopher R. K. Ching, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 519
Single-nucleus chromatin accessibility and transcriptomic characterization of Alzheimer’s disease
Samuel Morabito, Emily Miyoshi, Neethu Michael, et al.
Nature Genetics (2021) Vol. 53, Iss. 8, pp. 1143-1155
Open Access | Times Cited: 460
Amyloid-β-independent regulators of tau pathology in Alzheimer disease
Rik van der Kant, Lawrence S.B. Goldstein, Rik Ossenkoppele
Nature reviews. Neuroscience (2019) Vol. 21, Iss. 1, pp. 21-35
Closed Access | Times Cited: 448
Post-Stroke Cognitive Impairment and Dementia
Natalia S. Rost, Amy Brodtmann, Matthew P. Pase, et al.
Circulation Research (2022) Vol. 130, Iss. 8, pp. 1252-1271
Open Access | Times Cited: 444
Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression
Bing Bai, Xusheng Wang, Yuxin Li, et al.
Neuron (2020) Vol. 105, Iss. 6, pp. 975-991.e7
Open Access | Times Cited: 441
Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer’s disease risk genes
Jeremy Schwartzentruber, Sarah Cooper, Jimmy Z. Liu, et al.
Nature Genetics (2021) Vol. 53, Iss. 3, pp. 392-402
Open Access | Times Cited: 410
The multiplex model of the genetics of Alzheimer’s disease
Rebecca Sims, Matthew Hill, Julie Williams
Nature Neuroscience (2020) Vol. 23, Iss. 3, pp. 311-322
Open Access | Times Cited: 401
Objectives, design and main findings until 2020 from the Rotterdam Study
M. Arfan Ikram, Guy Brusselle, Mohsen Ghanbari, et al.
European Journal of Epidemiology (2020) Vol. 35, Iss. 5, pp. 483-517
Open Access | Times Cited: 397
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
Wouter van Rheenen, Rick A. A. van der Spek, Mark K. Bakker, et al.
Nature Genetics (2021) Vol. 53, Iss. 12, pp. 1636-1648
Open Access | Times Cited: 388
Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level
Erik C. B. Johnson, Kathleen Carter, Eric B. Dammer, et al.
Nature Neuroscience (2022) Vol. 25, Iss. 2, pp. 213-225
Open Access | Times Cited: 377
Modeling Alzheimer’s disease with iPSC-derived brain cells
Jay Penney, William T. Ralvenius, Li‐Huei Tsai
Molecular Psychiatry (2019) Vol. 25, Iss. 1, pp. 148-167
Open Access | Times Cited: 368
Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study
Eric M. Reiman, Joseph F. Arboleda‐Velásquez, Yakeel T. Quiroz, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 364
Page 1 - Next Page

Scroll to top